News | February 03, 2022
Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
It has a total of 50 ANDA approvals from USFDA
The need is to vaccinate people who have not contracted Covid-19
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
